TR200100107T2 - Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. - Google Patents
Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem.Info
- Publication number
- TR200100107T2 TR200100107T2 TR2001/00107T TR200100107T TR200100107T2 TR 200100107 T2 TR200100107 T2 TR 200100107T2 TR 2001/00107 T TR2001/00107 T TR 2001/00107T TR 200100107 T TR200100107 T TR 200100107T TR 200100107 T2 TR200100107 T2 TR 200100107T2
- Authority
- TR
- Turkey
- Prior art keywords
- polymer
- pharmaceutical form
- active ingredient
- programmed
- preparation
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 230000003111 delayed effect Effects 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9806384A FR2778848B1 (fr) | 1998-05-20 | 1998-05-20 | Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200100107T2 true TR200100107T2 (tr) | 2001-06-21 |
Family
ID=9526556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/00107T TR200100107T2 (tr) | 1998-05-20 | 1999-05-20 | Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1077687B1 (enExample) |
| JP (1) | JP2002515423A (enExample) |
| KR (1) | KR100583065B1 (enExample) |
| CN (1) | CN1186014C (enExample) |
| AT (1) | ATE214598T1 (enExample) |
| AU (1) | AU758299B2 (enExample) |
| BG (1) | BG64764B1 (enExample) |
| BR (1) | BR9910606A (enExample) |
| CA (1) | CA2333188C (enExample) |
| DE (1) | DE69901062T2 (enExample) |
| DK (1) | DK1077687T3 (enExample) |
| ES (1) | ES2173739T3 (enExample) |
| FR (1) | FR2778848B1 (enExample) |
| GE (1) | GEP20022750B (enExample) |
| HU (1) | HU224193B1 (enExample) |
| IL (1) | IL139774A (enExample) |
| MX (1) | MXPA00011364A (enExample) |
| NO (1) | NO330501B1 (enExample) |
| NZ (1) | NZ508392A (enExample) |
| PL (1) | PL192950B1 (enExample) |
| PT (1) | PT1077687E (enExample) |
| TR (1) | TR200100107T2 (enExample) |
| WO (1) | WO1999059557A1 (enExample) |
| ZA (1) | ZA200006768B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US8802139B2 (en) | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| EP2417969A1 (en) | 2004-10-21 | 2012-02-15 | Aptalis Pharmatech, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| AU2013273835B2 (en) * | 2005-05-02 | 2016-07-07 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| WO2008136016A1 (en) * | 2007-05-08 | 2008-11-13 | Medreich Limited | A stable controlled release oral solid dosage form composition and a process thereof |
| WO2011067667A2 (en) | 2009-12-02 | 2011-06-09 | Eurand Pharmaceuticals Limited | Fexofenadine microcapsules and compositions containing them |
| FR2999432B1 (fr) | 2012-12-17 | 2014-12-12 | Ethypharm Sa | Comprimes orodispersibles obtenus par compression moulage |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
| US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
| FR2754710B1 (fr) * | 1996-10-22 | 1998-12-31 | Prographarm Lab | Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle |
-
1998
- 1998-05-20 FR FR9806384A patent/FR2778848B1/fr not_active Expired - Lifetime
-
1999
- 1999-05-20 WO PCT/FR1999/001201 patent/WO1999059557A1/fr not_active Ceased
- 1999-05-20 HU HU0102027A patent/HU224193B1/hu active IP Right Grant
- 1999-05-20 AU AU38302/99A patent/AU758299B2/en not_active Expired
- 1999-05-20 PT PT99920897T patent/PT1077687E/pt unknown
- 1999-05-20 AT AT99920897T patent/ATE214598T1/de active
- 1999-05-20 GE GEAP19995632A patent/GEP20022750B/en unknown
- 1999-05-20 BR BR9910606-0A patent/BR9910606A/pt not_active Application Discontinuation
- 1999-05-20 IL IL13977499A patent/IL139774A/xx not_active IP Right Cessation
- 1999-05-20 DE DE69901062T patent/DE69901062T2/de not_active Expired - Lifetime
- 1999-05-20 ES ES99920897T patent/ES2173739T3/es not_active Expired - Lifetime
- 1999-05-20 JP JP2000549222A patent/JP2002515423A/ja active Pending
- 1999-05-20 EP EP99920897A patent/EP1077687B1/fr not_active Expired - Lifetime
- 1999-05-20 TR TR2001/00107T patent/TR200100107T2/xx unknown
- 1999-05-20 DK DK99920897T patent/DK1077687T3/da active
- 1999-05-20 NZ NZ508392A patent/NZ508392A/xx not_active IP Right Cessation
- 1999-05-20 CA CA2333188A patent/CA2333188C/fr not_active Expired - Lifetime
- 1999-05-20 CN CNB998074322A patent/CN1186014C/zh not_active Expired - Lifetime
- 1999-05-20 PL PL344314A patent/PL192950B1/pl unknown
- 1999-05-20 MX MXPA00011364A patent/MXPA00011364A/es active IP Right Grant
- 1999-05-20 KR KR1020007013020A patent/KR100583065B1/ko not_active Expired - Fee Related
-
2000
- 2000-11-17 NO NO20005838A patent/NO330501B1/no not_active IP Right Cessation
- 2000-11-17 BG BG104963A patent/BG64764B1/bg unknown
- 2000-11-20 ZA ZA200006768A patent/ZA200006768B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200100107T2 (tr) | Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. | |
| RU95105449A (ru) | Пероральный препарат морфина с регулируемым выделением активного компонента | |
| SE0001151D0 (sv) | Method for producing a controlled-release composition | |
| CA2292586A1 (en) | Solid pharmaceutical dosage forms in form of a particulate dispersion | |
| AU7495596A (en) | Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process | |
| HUP0004732A2 (hu) | Kapszulázási eljárás | |
| TR199901564T2 (xx) | H�zl� ��z�lebilen ve tat-maskesi sa�layan dozaj ispen�iyari formu. | |
| FR2775435B1 (fr) | Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs | |
| IS5577A (is) | Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar | |
| ATE288259T1 (de) | Verfahren zur herstellung fester oraler darreichungsformen mit retardierender wirkstofffreisetzung | |
| TR200200966T1 (tr) | Tüberkülöz ilaçlarının yeni farmasötik terkipleri ve hazırlanma prosesleri | |
| ATE204747T1 (de) | Retard-matrixpellets und verfahren zu ihrer herstellung | |
| SE8404467D0 (sv) | Controlled-release medical preparations | |
| NO20000284L (no) | Garvesyre-polymerblandinger for kontrollert frigivelse av farmasøytiske midler, særlig i munnhulen | |
| CA2170748A1 (en) | Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis | |
| ES2123477T3 (es) | Composicion biologicamente activa que comprende ciclosporina. | |
| EP0826375A3 (de) | Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen | |
| AU574220B2 (en) | Sustained release drug in ter polymer coat (pvc and pvacand pvom) | |
| EP0113776A1 (en) | Quinidine sustained release dosage formulation | |
| EP1258254A4 (en) | COMPOSITIONS FOR DELAYED DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THAT ARE LOW WATER-SOLUBLE, METHOD FOR THE PRODUCTION AND USE THEREOF | |
| DK0744947T3 (da) | Metronidazolpræparater med modificeret afgivelse og fremgangsmåde til deres fremstilling og anvendelse | |
| DK1417960T3 (da) | Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf | |
| ATE364403T1 (de) | Retardtablette hergestellt aus linearen wasserunlöslichen polysacchariden | |
| DE59410133D1 (de) | Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung | |
| WO2001040274A3 (en) | Inhibition of hrsv membrane fusion |